CytoDyn Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
CytoDyn Inc. (CYDY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 1.10% for the 12-month period ending 2015-05-31, per its 10-K filed 2015-07-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2015-07-10
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 1.10%, a 40.54% decline from fiscal 2014.
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2014 was 1.85%, a 164.29% increase from fiscal 2013.
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2013 was 0.70%, a 19.54% decline from fiscal 2012.
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2012 was 0.87%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|
| 2015-05-31 | 1.10% 10-K · filed 2015-07-10 |
| 2014-05-31 | 1.85% 10-K · filed 2015-07-10 |
| 2013-05-31 | 0.70% 10-K · filed 2014-07-10 |
| 2012-05-31 | 0.87% 10-K · filed 2013-08-29 |